カテゴリー： 世界, 部品/材料, MarketsandMarkets

世界の医薬品包装市場（～2027年）：原材料別（プラスチック、紙＆板紙、ガラス、金属）、種類別（プラスチックボトル、ブリスター、キャップ＆クローサー、ラベル＆付属品、プレフィルドシリンジ）、薬物送達別、地域別

【英語タイトル】Pharmaceutical Packaging Market by Raw Material (Plastics, Paper & paperboard, Glass, Metal), Type (Plastic Bottles, Blisters, Caps & Closures, Labels & Accessories, Pre-filled syringes), Drug Delivery, and Region - Global Forecast to 2027

MarketsandMarketsが出版した調査資料（CH3482-23）・商品コード：CH3482-23
・発行会社（調査会社）：MarketsandMarkets
・発行日：2023年1月12日
・ページ数：315
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後24時間以内）
・調査対象地域：グローバル
・産業分野：化学
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD4,950 ⇒換算￥752,400見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥1,010,800見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥1,238,800見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

MarketsandMarkets社は、世界の医薬品包装市場規模が2021年999億ドルから2027年2,299億ドルに達し、予測期間中に年平均14.9％で成長すると予測しています。本調査レポートでは、医薬品包装の世界市場を調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、原材料別（プラスチック、紙＆板紙、ガラス、金属、その他）分析、種類別（プラスチックボトル、ブリスター、ラベル＆付属品、キャップ＆クローサー、プレフィルドシリンジ）分析、薬物送達別（経口、注射、局所、眼科用、点鼻）分析、地域別（北米、ヨーロッパ、アジア太平洋、南米、中東・アフリカ）分析、競争状況、企業情報などの項目を掲載しています。なお、当書に掲載されている企業情報には、Schott AG (Germany)、Amcor PLC (Switzerland)、AptarGroup,Inc (US)、West Pharmaceutical Services、Inc. (US)、Berry Global (US)、Gerresheimer AG (Germany)、Catalent,Inc (US)、WestRock (US)などが含まれています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界の医薬品包装市場規模：原材料別
- プラスチックの市場規模
- 紙＆板紙の市場規模
- ガラスの市場規模
- 金属の市場規模
- その他原材の市場規模
・世界の医薬品包装市場規模：種類別
- プラスチックボトルの市場規模
- ブリスターの市場規模模
- ラベル＆付属品の市場規模模
- キャップ＆クローサーの市場規模模
- プレフィルドシリンジの市場規模模
・世界の医薬品包装市場規模：薬物送達別
- 経口剤の市場規模
- 注射剤の市場規模
- 局所剤の市場規模
- 眼科用薬の市場規模
- 点鼻剤の市場規模
・世界の医薬品包装市場規模：地域別
- 北米の医薬品包装市場規模
- ヨーロッパの医薬品包装市場規模
- アジア太平洋の医薬品包装市場規模
- 南米の医薬品包装市場規模
- 中東・アフリカの医薬品包装市場規模
・競争状況
・企業情報

“世界の医薬品包装市場規模は、2021年の999億米ドルから2027年には2,299億米ドルに達し、予測期間中の年平均成長率は14.9%と予測、2021年の市場シェアは一次包装が最大”
医療費の増加や、より健康的なライフスタイルに関する消費者の意識の高まりにより、新興市場における医薬品包装の需要が増え続けています。さらに、アジア太平洋、南米、中東・アフリカなどの新興国における医薬品包装の需要は、医療へのより良いアクセスを提供するための政府による大規模な投資のために増加しており、がん、感染症などの慢性疾患の発生が増加していることも、予測期間中に医薬品包装の市場を牽引すると期待されています。

“医薬品包装市場における他の原材料の中で紙・板紙が第2位のシェアを占める”
紙・板紙は医薬品のラベルや二次容器として大きな需要があります。これらの包装は、ハイエンドのグラフィックを使用することで、顧客の関心を引き、包装されている製品の重要な情報を提供するだけでなく、完全な構造的サポートを可能にします。板紙シートを適切な形状にカットし、折り曲げ、接着します。必要に応じて角を補強し、段ボール箱、折りたたみカートン、トレイとして製造することができます。快適さ、丈夫さ、効果的な製品保護を提供します。

“医薬品包装市場において、ブリスターは他のタイプの中で2番目の市場シェアを占める”
ブリスターパックは熱成形プラスチックで作られ、一般的に板紙またはアルミニウムの裏打ち／蓋がついています。アルミ蓋は接着剤でコーティングされ、加熱することでブリスターパックに被せられ、密封されたパッケージを形成します。ブリスターパックは湿気、汚染、紫外線などの外的要因から医薬品を保護します。また、ブリスターパックは経口固形剤やカプセルの効率的で安全な薬物送達を実現します。

“注射剤は、2021年に他の中で2番目に大きな医薬品包装の薬物送達様式になると予想”
注射薬送達システムは、標的部位に到達する速度と有効性により、最も効果的で成功した薬剤投与経路の1つと考えられています。薬剤の大半は経口または注射によって送達されます。注射剤には、自己注射器、プレフィルドシリンジ、自動注射器、安全注射器、パッチ注射器、ペン型注射器などがあります。技術の進歩により、改良・強化された様々な器具が開発されています。さらに、生物製剤市場の発展が、予測期間中の注射剤市場を押し上げると予想されています。

“南米は予測期間中、医薬品包装市場で2番目に急成長すると予測”
南米は、2021年の医薬品包装市場において、金額ベースで他の地域の中で2番目に急成長する地域と予測されています。ブラジルとアルゼンチンがこの地域の主要市場であり、高い成長率を示しています。可処分所得の増加、医薬品需要の増加、高齢化、政府政策の改善により、医薬品包装市場は今後5年間でさらに成長する見込みです。ジェネリック医薬品の生産拡大、安価な生産コスト、品質保証が、この地域のプラスチックボトルと経口デリバリーシステム市場を牽引しています。
二次調査で収集した医薬品包装市場のいくつかのセグメントとサブセグメントのサイズを決定し検証する過程で、広範な一次インタビューを実施しました。

一次インタビューの内訳は以下の通りです
– 企業タイプ別 ティア1：25％、ティア2：50％、ティア3：25％
– 役職別 Cレベル：20％、ディレクターレベル：30％、その他：50％
– 地域別 北米20％、アジア太平洋25％、欧州30％、中東・アフリカ10％、南米15％

この市場の主要企業は、SSchott AG (Germany), Amcor PLC (Switzerland), AptarGroup,Inc (US), West Pharmaceutical Services, Inc. (US), Berry Global (US), Gerresheimer AG (Germany), Catalent,Inc (US), and WestRock (US)です。医薬品包装市場レポートでは、市場ポジションを強化するための新製品発売、投資＆拡張、契約、パートナーシップ、M＆Aなどの主要な成長戦略を分析しています。

調査範囲
本レポートでは、医薬品包装市場を詳細に区分し、2027年までの市場規模を予測しています。市場は原料、タイプ、薬物送達、地域に基づいてセグメント化されています。また、主要企業が市場での地位を強化するために採用した企業プロファイルや競争戦略に関する詳細情報も提供しています。また、医薬品包装市場の推進要因と抑制要因、これらの業界全体の機会と課題に関する洞察も提供しています。市場のトップメーカーのプロフィールも掲載しています。

レポート購入の理由
洞察の観点から、この調査レポートは様々なレベルの分析に焦点を当てています。業界分析（業界動向）、トッププレイヤーの市場ランキング、企業プロファイル、医薬品包装市場の新興および高成長セグメント、高成長地域、市場促進要因、抑制要因、機会、課題などとともに競争環境に関する基本的な見解を構成し、議論しています。

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 INTRODUCTION 38
1.1 STUDY OBJECTIVES 38
1.2 MARKET DEFINITION 38
1.3 STUDY SCOPE 39
FIGURE 1 PHARMACEUTICAL PACKAGING MARKET SEGMENTATION 39
1.3.1 REGIONS COVERED 39
1.3.2 YEARS CONSIDERED 40
1.4 CURRENCY CONSIDERED 40
1.5 UNIT CONSIDERED 40
1.6 STAKEHOLDERS 40
1.7 INCLUSIONS & EXCLUSIONS 41
TABLE 1 PHARMACEUTICAL PACKAGING MARKET: INCLUSIONS & EXCLUSIONS 41
1.8 SUMMARY OF CHANGES 42
1.9 LIMITATIONS 42
2 RESEARCH METHODOLOGY 43
2.1 IMPACT OF RECESSION 43
2.2 RESEARCH DATA 43
FIGURE 2 PHARMACEUTICAL PACKAGING MARKET: RESEARCH DESIGN 44
2.2.1 SECONDARY DATA 44
2.2.1.1 Major secondary sources 45
2.2.1.2 Key data from secondary sources 45
2.2.2 PRIMARY DATA 46
2.2.3 PRIMARY INTERVIEWS 46
2.2.3.1 Demand and supply sides 46
2.2.3.2 Key data from primary sources 47
2.2.3.3 Key industry insights 47
2.2.3.4 Breakdown of primary interviews 48
2.3 MARKET SIZE ESTIMATION 48
2.3.1 BOTTOM-UP APPROACH 49
FIGURE 3 PHARMACEUTICAL PACKAGING MARKET: BOTTOM-UP APPROACH 49
2.3.2 TOP-DOWN APPROACH 49
FIGURE 4 PHARMACEUTICAL PACKAGING MARKET: TOP-DOWN APPROACH 49
2.4 DATA TRIANGULATION 50
FIGURE 5 PHARMACEUTICAL PACKAGING MARKET: DATA TRIANGULATION 50
2.4.1 PHARMACEUTICAL PACKAGING MARKET ANALYSIS THROUGH PRIMARY INTERVIEWS 51
2.4.2 PHARMACEUTICAL PACKAGING MARKET ANALYSIS THROUGH SECONDARY SOURCES 51
FIGURE 6 PHARMACEUTICAL PACKAGING MARKET ANALYSIS 52
2.5 RESEARCH LIMITATIONS 52
2.6 RESEARCH ASSUMPTIONS 53
2.7 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST 53
2.7.1 SUPPLY SIDE 53
2.7.2 DEMAND SIDE 54
2.7.3 INSIGHTS FROM KEY RESPONDENTS 54
2.8 RISK ASSESSMENT 55
3 EXECUTIVE SUMMARY 56
FIGURE 7 PLASTIC BOTTLES TO BE LARGEST TYPE OF PHARMACEUTICAL PACKAGING 57
FIGURE 8 PLASTICS TO BE LARGEST RAW MATERIAL FOR PHARMACEUTICAL PACKAGING 58
FIGURE 9 ORAL DRUG DELIVERY MODE TO BE LARGEST SEGMENT OF PHARMACEUTICAL PACKAGING MARKET 58
FIGURE 10 ASIA PACIFIC TO BE FASTEST-GROWING PHARMACEUTICAL PACKAGING MARKET 59
4 PREMIUM INSIGHTS 60
4.1 EMERGING ECONOMIES TO WITNESS HIGH GROWTH DURING FORECAST PERIOD 60
FIGURE 11 ASIA PACIFIC TO OFFER ATTRACTIVE OPPORTUNITIES IN PHARMACEUTICAL PACKAGING MARKET 60
4.2 PHARMACEUTICAL PACKAGING MARKET, BY TYPE 61
FIGURE 12 PLASTIC BOTTLES SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 61
4.3 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL 61
FIGURE 13 PLASTICS SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 61
4.4 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY MODE 62
FIGURE 14 ORAL DRUG DELIVERY MODE TO LEAD MARKET BY 2027 62
4.5 GLOBAL PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY 62
FIGURE 15 MARKET IN INDIA TO GROW AT HIGHEST CAGR 62
5 MARKET OVERVIEW 63
5.1 INTRODUCTION 63
5.2 MARKET DYNAMICS 63
FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN PHARMACEUTICAL PACKAGING MARKET 63
5.2.1 DRIVERS 64
5.2.1.1 Growing healthcare expenditure and pharmaceutical industry in emerging economies 64
5.2.1.2 Rising demand for drug delivery devices and blister packaging 65
5.2.1.3 Technological advancements 66
5.2.1.3.1 Nanomedicine and nano drug delivery systems (NDDS) 66
5.2.1.3.2 Child-resistant packaging (CRP) 66
5.2.1.3.3 Radio-frequency identification (RFID) 66
5.2.1.3.4 Micropump technology 67
5.2.1.3.5 Eco-friendly and sustainable packaging 67
5.2.2 RESTRAINTS 67
5.2.2.1 Increasing overall packaging costs due to dynamic regulatory policies 67
5.2.2.2 Lack of access to proper healthcare in emerging economies 68
5.2.3 OPPORTUNITIES 68
5.2.3.1 Growing demand for primary pharmaceutical packaging 68
5.2.4 CHALLENGES 69
5.2.4.1 Safeguarding against counterfeit products 69
5.3 VALUE CHAIN ANALYSIS 70
FIGURE 17 PHARMACEUTICAL PACKAGING MARKET: VALUE CHAIN ANALYSIS 70
5.3.1 RAW MATERIAL SUPPLIERS 70
5.3.2 R&D OF PRODUCTS 71
5.3.3 MANUFACTURERS 71
5.3.4 DISTRIBUTORS 71
5.3.5 END USERS 71
TABLE 2 PHARMACEUTICAL PACKAGING MARKET: VALUE CHAIN STAKEHOLDERS 72
5.4 PORTER’S FIVE FORCES ANALYSIS 73
FIGURE 18 PORTER’S FIVE FORCES ANALYSIS: PHARMACEUTICAL PACKAGING MARKET 73
5.4.1 THREAT OF NEW ENTRANTS 73
5.4.2 THREAT OF SUBSTITUTES 74
5.4.3 BARGAINING POWER OF BUYERS 74
5.4.4 BARGAINING POWER OF SUPPLIERS 74
5.4.5 INTENSITY OF COMPETITIVE RIVALRY 75
TABLE 3 IMPACT OF PORTER’S FIVE FORCES ON PHARMACEUTICAL PACKAGING MARKET 75
5.5 MACROECONOMIC INDICATORS 75
5.5.1 GLOBAL GDP TRENDS 75
TABLE 4 TRENDS OF PER CAPITA GDP (USD) 2019–2021 75
TABLE 5 GDP GROWTH ESTIMATE AND PROJECTION OF KEY COUNTRIES, 2022–2027 76
TABLE 6 CURRENT HEALTH EXPENDITURE (% OF GDP) OF KEY COUNTRIES, 2018–2019 77
5.6 REGULATORY LANDSCAPE 78
5.6.1 REGULATIONS 78
5.6.1.1 Europe 78
5.6.1.2 US 78
5.6.1.3 Others 78
5.7 TECHNOLOGY ANALYSIS 79
5.7.1 NANOTECHNOLOGY 79
5.7.2 PACKAGING FOR BIOLOGICS 79
5.7.3 SMART PACKAGING 79
5.7.4 ANTI-COUNTERFEIT PACKAGING 79
5.7.5 OTHER SMART TRENDS AND TECHNOLOGIES 80
5.8 PRICING ANALYSIS 80
5.8.1 AVERAGE SELLING PRICE, BY REGION 80
FIGURE 19 AVERAGE SELLING PRICE, BY REGION (USD/KG) 80
5.8.2 AVERAGE SELLING PRICE, BY RAW MATERIAL 81
TABLE 7 AVERAGE SELLING PRICE, BY RAW MATERIAL (USD/KG) 81
5.8.3 AVERAGE SELLING PRICE, BY COMPANY 81
TABLE 8 AVERAGE SELLING PRICE, BY COMPANY (USD/KG) 81
5.9 PHARMACEUTICAL PACKAGING MARKET: ECOSYSTEM MAPPING 82
FIGURE 20 PHARMACEUTICAL PACKAGING MARKET: ECOSYSTEM MAPPING 82
5.10 IMPACT OF COVID-19 ON PHARMACEUTICAL PACKAGING MARKET 83
5.10.1 IMPACT ON HEALTHCARE INDUSTRY 83
5.11 IMPACT OF RECESSION ON PHARMACEUTICAL PACKAGING MARKET 84
5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 84
FIGURE 21 SUSTAINABLE PACKAGING, IOT, AND NANOTECHNOLOGY TO DRIVE GROWTH 84
5.13 PATENT ANALYSIS 85
5.13.1 INTRODUCTION 85
5.13.2 METHODOLOGY 85
5.13.3 DOCUMENT TYPE 85
FIGURE 22 PATENTS REGISTERED (2011–2021) 85
5.13.4 PUBLICATION TRENDS – LAST 10 YEARS 86
FIGURE 23 NUMBER OF PATENTS IN LAST 10 YEARS, 2011–2021 86
5.13.5 INSIGHTS 86
5.13.6 JURISDICTION ANALYSIS 86
FIGURE 24 TOP JURISDICTIONS 86
5.13.7 TOP PATENT APPLICANTS 87
FIGURE 25 TOP 10 PATENT APPLICANTS 87
TABLE 9 LIST OF PATENTS BY SANOFI AVENTIS DEUTSCHLAND 88
TABLE 10 LIST OF PATENTS BY SCHOTT AG 88
TABLE 11 LIST OF PATENTS BY TERUMO CORP 89
TABLE 12 LIST OF PATENTS BY BECTON DICKINSON AND COMPANY 90
TABLE 13 TOP 10 PATENT OWNERS (US) IN LAST 10 YEARS 90
5.14 RAW MATERIAL ANALYSIS 91
5.14.1 PLASTICS 91
5.14.2 PAPER 91
5.14.3 GLASS 91
5.14.4 METALS 91
5.15 TRADE ANALYSIS 92
5.16 OPERATIONAL DATA 93
5.17 KEY CONFERENCES AND EVENTS (2022–2023) 93
TABLE 14 KEY CONFERENCES AND EVENTS (2022–2023) 93

5.18 CASE STUDY ANALYSIS 94
5.18.1 MOISTURE BARRIER TECHNOLOGY FOR BETTER DRUG DELIVERY 94
5.18.2 CUSTOM TECHNOLOGY FOR BETTER BREATHING 95
6 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL 96
6.1 INTRODUCTION 97
FIGURE 26 PLASTICS SEGMENT TO DOMINATE PHARMACEUTICAL PACKAGING MARKET 97
TABLE 15 BASIC PACKAGING RAW MATERIALS USED IN PHARMACEUTICAL PACKAGING 97
TABLE 16 RAW MATERIAL: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 98
TABLE 17 RAW MATERIAL: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 99
TABLE 18 RAW MATERIAL: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (KILOTON) 99
TABLE 19 RAW MATERIAL: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (KILOTON) 99
TABLE 20 PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (USD MILLION) 100
TABLE 21 PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (USD MILLION) 100
TABLE 22 PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (KILOTON) 100
TABLE 23 PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (KILOTON) 101
6.2 PLASTICS 101
6.2.1 EXCELLENT SHATTER RESISTANCE OF PLASTICS TO BOOST ITS USE IN PRIMARY PACKAGING 101
TABLE 24 PLASTICS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 101
TABLE 25 PLASTICS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 102
TABLE 26 PLASTICS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (KILOTON) 102
TABLE 27 PLASTICS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (KILOTON) 102
6.2.2 HIGH-DENSITY POLYETHYLENE (HDPE) 103
6.2.3 POLYESTER 103
6.2.4 POLYPROPYLENE (PP) 103
6.2.5 LOW-DENSITY POLYETHYLENE (LDPE) 103
6.2.6 POLYVINYL CHLORIDE (PVC) 103
6.2.7 CYCLIC OLEFIN COPOLYMER (COC) 104
6.2.8 POLYETHYLENE TEREPHTHALATE (PET) 104

6.3 PAPER & PAPERBOARD 104
6.3.1 INNOVATIONS IN SECONDARY PACKAGING TO PROPEL USE OF PAPER & PAPERBOARD 104
TABLE 28 PAPER & PAPERBOARD: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 105
TABLE 29 PAPER & PAPERBOARD: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 105
TABLE 30 PAPER & PAPERBOARD: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (KILOTON) 105
TABLE 31 PAPER & PAPERBOARD: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (KILOTON) 106
6.4 GLASS 106
6.4.1 EXCELLENT CHEMICAL RESISTANCE OF GLASS TO BOOST ITS USE IN PRIMARY PACKAGING 106
TABLE 32 GLASS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 107
TABLE 33 GLASS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 107
TABLE 34 GLASS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (KILOTON) 107
TABLE 35 GLASS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (KILOTON) 108
TABLE 36 TYPES OF GLASS USED FOR DIFFERENT PACKAGING 109
6.5 METALS 109
6.5.1 INCREASING USE OF ALUMINUM FOR BLISTER PACKAGING TO BOOST MARKET 109
TABLE 37 METALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 110
TABLE 38 METALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 110
TABLE 39 METALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (KILOTON) 110
TABLE 40 METALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (KILOTON) 111
6.6 OTHERS 111
TABLE 41 OTHER RAW MATERIALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 112
TABLE 42 OTHER RAW MATERIALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 112
TABLE 43 OTHER RAW MATERIALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (KILOTON) 112
TABLE 44 OTHER RAW MATERIALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (KILOTON) 113

7 PHARMACEUTICAL PACKAGING MARKET, BY TYPE 114
7.1 INTRODUCTION 115
FIGURE 27 PLASTIC BOTTLES ACCOUNTED FOR LARGEST SHARE OF PHARMACEUTICAL PACKAGING MARKET 115
TABLE 45 PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 116
TABLE 46 PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 117
TABLE 47 PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018–2021 (USD MILLION) 117
TABLE 48 PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2022–2027 (USD MILLION) 117
7.2 PLASTIC BOTTLES 118
7.2.1 EASY OPERABILITY, SHATTER RESISTANCE, AND LIGHTWEIGHT PROPERTIES TO DRIVE DEMAND 118
TABLE 49 PLASTIC BOTTLES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 118
TABLE 50 PLASTIC BOTTLES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 119
7.2.2 STANDARD PLASTIC BOTTLES 119
7.2.3 PLASTIC DISPENSING BOTTLES 119
7.2.4 PLASTIC JARS 119
7.3 BLISTER PACKS 119
7.3.1 EFFECTIVE DRUG PROTECTION AND EASY MANUFACTURING TO DRIVE MARKET 119
TABLE 51 BLISTER PACKS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 120
TABLE 52 BLISTER PACKS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 120
7.3.2 COMPARTMENT PACKS 120
7.3.3 WALLET PACKS 120
7.4 LABELS & ACCESSORIES 121
7.4.1 PATIENT-DRUG COMMUNICATION COMPLIANCE TO BOOST DEMAND 121
TABLE 53 LABELS & ACCESSORIES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 121
TABLE 54 LABELS & ACCESSORIES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 121
7.4.2 SELF-ADHESIVE LABELS 122
7.4.3 DIE-CUT LABELS 122
7.4.4 TAMPER-PROOF LABELS 122
7.4.5 HOLOGRAPHIC STRIP LABELS 122

7.5 CAPS & CLOSURES 122
7.5.1 DEMAND FOR TAMPER-EVIDENT PACKAGING TO PROPEL MARKET 122
TABLE 55 CAPS & CLOSURES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 123
TABLE 56 CAPS & CLOSURES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 123
7.6 MEDICAL SPECIALTY BAGS 123
7.6.1 EASY HANDLING AND DISPOSABLE CHARACTERISTICS TO FUEL DEMAND 123
TABLE 57 MEDICAL SPECIALTY BAGS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 124
TABLE 58 MEDICAL SPECIALTY BAGS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 124
7.7 PREFILLED SYRINGES 124
7.7.1 SELF-MEDICATION AND INCREASING CHRONIC DISEASES TO DRIVE DEMAND 124
TABLE 59 PREFILLED SYRINGES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 125
TABLE 60 PREFILLED SYRINGES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 125
7.8 TEMPERATURE-CONTROLLED PACKAGING 126
7.8.1 INCREASING MANUFACTURING OF SPECIALIZED DRUGS TO FUEL MARKET 126
TABLE 61 TEMPERATURE-CONTROLLED PACKAGING: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 126
TABLE 62 TEMPERATURE CONTROLLED PACKAGING: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 126
7.9 POUCHES & STRIP PACKS 127
7.9.1 INCREASING DEMAND FOR STANDUP POUCHES TO OFFER GROWTH OPPORTUNITIES 127
TABLE 63 POUCHES & STRIP PACKS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 127
TABLE 64 POUCHES & STRIP PACKS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 127
7.10 AMPOULES 128
7.10.1 INCREASING DEMAND FROM DEVELOPING COUNTRIES TO DRIVE MARKET 128
TABLE 65 AMPOULES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 128
TABLE 66 AMPOULES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 128
7.11 VIALS 129
7.11.1 DEMAND FOR VIALS IN VACCINE PACKAGING TO SUPPORT MARKET GROWTH 129
TABLE 67 VIALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 129
TABLE 68 VIALS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 129
7.12 PREFILLED INHALERS 130
7.12.1 INCREASING CASES OF PULMONARY DISEASES TO DRIVE DEMAND 130
TABLE 69 PREFILLED INHALERS: PHARMACEUTICAL PACKAGING MARKET SIZE,
BY REGION, 2018–2021 (USD MILLION) 130
TABLE 70 PREFILLED INHALERS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 130
7.12.2 METERED DOSE INHALERS 131
7.12.3 DRY POWDER INHALERS 131
7.13 MEDICATION TUBES 131
7.13.1 EASE OF USE TO INCREASE DEMAND 131
TABLE 71 MEDICATION TUBES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 131
TABLE 72 MEDICATION TUBES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 132
7.13.2 COMPOSITE TUBES 132
7.13.3 ALL-PLASTIC TUBES 132
7.13.4 COLLAPSIBLE METAL TUBES 132
7.14 JARS & CANISTERS 132
7.14.1 EFFECTIVE BARRIER PROPERTIES TO PROPEL DEMAND 132
TABLE 73 JARS & CANISTERS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 133
TABLE 74 JARS & CANISTERS: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 133
7.15 CARTRIDGES 133
7.15.1 COMPATIBILITY WITH A VARIETY OF DEVICES TO DRIVE MARKET 133
TABLE 75 CARTRIDGES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 134
TABLE 76 CARTRIDGES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 134
7.16 OTHERS 134
TABLE 77 OTHER TYPES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 134
TABLE 78 OTHER TYPES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 135
8 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY MODE 136
8.1 INTRODUCTION 137
FIGURE 28 ORAL DRUG DELIVERY MODE TO BE LARGEST SEGMENT IN 2022 137
TABLE 79 DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 138
TABLE 80 DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 138
TABLE 81 PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY, 2018–2021 (USD MILLION) 138
TABLE 82 PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY, 2022–2027 (USD MILLION) 139
8.2 ORAL DRUG DELIVERY MODE 139
8.2.1 HIGH DEMAND FOR ORAL DRUG DELIVERY MODE OWING TO EASE OF USE 139
TABLE 83 ORAL DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 140
TABLE 84 ORAL DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 140
8.3 INJECTABLE DRUG DELIVERY MODE 140
8.3.1 HIGH BIOAVAILABILITY AND EFFICIENT TREATMENT TO BOOST THIS SEGMENT 140
TABLE 85 INJECTABLE DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 141
TABLE 86 INJECTABLE DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 141
8.4 TOPICAL DRUG DELIVERY MODE 141
8.4.1 PREVALENCE OF SKIN DISEASES TO DRIVE MARKET FOR TOPICAL FORMULATIONS 141
TABLE 87 TOPICAL DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 142
TABLE 88 TOPICAL DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 142
8.5 OCULAR/OPHTHALMIC DRUG DELIVERY MODE 142
8.5.1 INCREASING PREVALENCE OF EYE DISORDERS AND AGING POPULATION TO FUEL CONSUMPTION 142
TABLE 89 OCULAR/OPHTHALMIC DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 143
TABLE 90 OCULAR/OPHTHALMIC DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 143
8.6 NASAL DRUG DELIVERY MODE 143
8.6.1 RAPID ABSORPTION AND FASTER ONSET OF ACTION TO PROPEL MARKET 143
TABLE 91 NASAL DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 144
TABLE 92 NASAL DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 144
8.7 PULMONARY DRUG DELIVERY MODE 145
8.7.1 INCREASING CASES OF LUNG-RELATED DISEASES TO BOOST DEMAND 145
TABLE 93 PULMONARY DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 145
TABLE 94 PULMONARY DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 146
8.8 TRANSDERMAL DRUG DELIVERY MODE 146
8.8.1 INCREASING SMALL-DOSE DRUG USE TO FUEL MARKET 146
TABLE 95 TRANSDERMAL DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 147
TABLE 96 TRANSDERMAL DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 147
8.9 IV DRUG DELIVERY MODE 147
8.9.1 IMPROVED PATIENT COMPLIANCE AND HIGH DRUG DOSE CAPABILITY TO DRIVE DEMAND 147
TABLE 97 IV DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 148
TABLE 98 IV DRUG DELIVERY MODE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 148
8.10 OTHER DRUG DELIVERY MODES 148
TABLE 99 OTHER DRUG DELIVERY MODES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 149
TABLE 100 OTHER DRUG DELIVERY MODES: PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 149
9 PHARMACEUTICAL PACKAGING MARKET, BY REGION 150
9.1 INTRODUCTION 151
FIGURE 29 PHARMACEUTICAL PACKAGING MARKET IN INDIA TO REGISTER HIGHEST CAGR 151
TABLE 101 PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2018–2021 (USD MILLION) 151
TABLE 102 PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2022–2027 (USD MILLION) 152
9.2 NORTH AMERICA 152
9.2.1 RECESSION IMPACT 152
FIGURE 30 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SNAPSHOT 153
TABLE 103 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2018–2021 (USD MILLION) 153
TABLE 104 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION) 154
TABLE 105 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 154
TABLE 106 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 155
TABLE 107 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018–2021 (USD MILLION) 155
TABLE 108 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2022–2027 (USD MILLION) 155
TABLE 109 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2018–2021 (USD MILLION) 156
TABLE 110 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2022–2027 (USD MILLION) 156
TABLE 111 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (USD MILLION) 157
TABLE 112 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (USD MILLION) 157
TABLE 113 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (KILOTON) 157
TABLE 114 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (KILOTON) 158
9.2.2 US 158
9.2.2.1 Rapid technological advancements 158
TABLE 115 US: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 159
TABLE 116 US: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 160
9.2.3 CANADA 160
9.2.3.1 Competitive business environment to boost market 160
TABLE 117 CANADA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 161
TABLE 118 CANADA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 162
9.2.4 MEXICO 162
9.2.4.1 Government initiatives in healthcare industry to fuel demand 162
TABLE 119 MEXICO: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 163
TABLE 120 MEXICO: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 164
9.3 EUROPE 164
9.3.1 RECESSION IMPACT 165
TABLE 121 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2018–2021 (USD MILLION) 165
TABLE 122 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION) 165
TABLE 123 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 166
TABLE 124 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 167
TABLE 125 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018–2021 (USD MILLION) 167
TABLE 126 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2022–2027 (USD MILLION) 167
TABLE 127 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2018–2021 (USD MILLION) 168
TABLE 128 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2022–2027 (USD MILLION) 168
TABLE 129 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (USD MILLION) 169
TABLE 130 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (USD MILLION) 169
TABLE 131 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (KILOTON) 169
TABLE 132 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (KILOTON) 170
9.3.2 GERMANY 170
9.3.2.1 Increase in aging population and non-communicable diseases to drive market 170
TABLE 133 GERMANY: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 171
TABLE 134 GERMANY: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 172
9.3.3 FRANCE 172
9.3.3.1 High demand for generic drugs to drive market 172
TABLE 135 FRANCE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 173
TABLE 136 FRANCE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 174
9.3.4 ITALY 174
9.3.4.1 Growing exports of pharmaceuticals to impact market growth 174
TABLE 137 ITALY: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 175
TABLE 138 ITALY: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 176
9.3.5 UK 176
9.3.5.1 Innovation in drug manufacturing to increase demand 176
TABLE 139 UK: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 177
TABLE 140 UK: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 178
9.3.6 SPAIN 178
9.3.6.1 Government initiatives in healthcare sector to boost demand 178
TABLE 141 SPAIN: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 179
TABLE 142 SPAIN: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 180
9.3.7 RUSSIA 180
9.3.7.1 Government initiatives for domestic production of pharmaceuticals to fuel market 180
TABLE 143 RUSSIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 181
TABLE 144 RUSSIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 182
9.3.8 REST OF EUROPE 182
TABLE 145 REST OF EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 183
TABLE 146 REST OF EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 184
9.4 ASIA PACIFIC 184
9.4.1 RECESSION IMPACT 184
FIGURE 31 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SNAPSHOT 185
TABLE 147 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2018–2021 (USD MILLION) 186
TABLE 148 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION) 186
TABLE 149 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 187
TABLE 150 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 188
TABLE 151 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018–2021 (USD MILLION) 188
TABLE 152 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2022–2027 (USD MILLION) 188
TABLE 153 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2018–2021 (USD MILLION) 189
TABLE 154 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2022–2027 (USD MILLION) 189
TABLE 155 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (USD MILLION) 190
TABLE 156 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (USD MILLION) 190
TABLE 157 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (KILOTON) 190
TABLE 158 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (KILOTON) 191
9.4.2 CHINA 191
9.4.2.1 Increased investments in R&D of biologics and biosimilar drugs to drive market 191
TABLE 159 CHINA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 192
TABLE 160 CHINA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 193
9.4.3 JAPAN 193
9.4.3.1 Sizeable aging population to drive demand for medications 193
TABLE 161 JAPAN: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 194
TABLE 162 JAPAN: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 195
9.4.4 SOUTH KOREA 195
9.4.4.1 Well-developed healthcare industry and presence of major pharmaceuticals manufacturers to drive market 195
TABLE 163 SOUTH KOREA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 196
TABLE 164 SOUTH KOREA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 197
9.4.5 INDIA 197
9.4.5.1 Large domestic consumption and export of generic drugs to drive market 197
TABLE 165 INDIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 199
TABLE 166 INDIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 200
9.4.6 AUSTRALIA 200
9.4.6.1 Medicare and PBS schemes strengthening country’s pharmaceutical industry to drive market 200
TABLE 167 AUSTRALIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 201
TABLE 168 AUSTRALIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 202
9.4.7 REST OF ASIA PACIFIC 202
TABLE 169 REST OF ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 203
TABLE 170 REST OF ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 204
9.5 SOUTH AMERICA 204
9.5.1 RECESSION IMPACT 205
TABLE 171 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2018–2021 (USD MILLION) 205
TABLE 172 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION) 205
TABLE 173 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 206
TABLE 174 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 207
TABLE 175 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018–2021 (USD MILLION) 207
TABLE 176 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2022–2027 (USD MILLION) 207
TABLE 177 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2018–2021 (USD MILLION) 208
TABLE 178 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2022–2027 (USD MILLION) 208
TABLE 179 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (USD MILLION) 209
TABLE 180 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (USD MILLION) 209
TABLE 181 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (KILOTON) 209
TABLE 182 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (KILOTON) 210
9.5.2 BRAZIL 210
9.5.2.1 Free and universal healthcare services to support growth of pharmaceutical industry 210
TABLE 183 BRAZIL: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 211
TABLE 184 BRAZIL: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 212
9.5.3 ARGENTINA 212
9.5.3.1 Plastic bottles to account for largest market share 212
TABLE 185 ARGENTINA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 213
TABLE 186 ARGENTINA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 214
9.5.4 REST OF SOUTH AMERICA 214
TABLE 187 REST OF SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 215
TABLE 188 REST OF SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 216

9.6 MIDDLE EAST & AFRICA 216
9.6.1 RECESSION IMPACT 217
TABLE 189 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2018–2021 (USD MILLION) 217
TABLE 190 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION) 217
TABLE 191 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 218
TABLE 192 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 219
TABLE 193 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018–2021 (USD MILLION) 219
TABLE 194 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2022–2027 (USD MILLION) 219
TABLE 195 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2018–2021 (USD MILLION) 220
TABLE 196 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY MODE, 2022–2027 (USD MILLION) 220
TABLE 197 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (USD MILLION) 221
TABLE 198 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (USD MILLION) 221
TABLE 199 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2018–2021 (KILOTON) 221
TABLE 200 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2022–2027 (KILOTON) 222
9.6.2 SAUDI ARABIA 222
9.6.2.1 Wider access to healthcare services to increase demand for pharmaceuticals 222
TABLE 201 SAUDI ARABIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 223
TABLE 202 SAUDI ARABIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 224
9.6.3 SOUTH AFRICA 224
9.6.3.1 Gradual rise in generic drug use to fuel pharmaceutical packaging market 224
TABLE 203 SOUTH AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 225
TABLE 204 SOUTH AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 226
9.6.4 UAE 226
9.6.4.1 Increasing initiatives for domestic pharmaceutical production to drive market 226
TABLE 205 UAE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 227
TABLE 206 UAE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 228
9.6.5 REST OF MIDDLE EAST & AFRICA 228
TABLE 207 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2018–2021 (USD MILLION) 229
TABLE 208 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION) 230
10 COMPETITIVE LANDSCAPE 231
10.1 OVERVIEW 231
10.2 STRATEGIES ADOPTED BY KEY PLAYERS 232
FIGURE 32 COMPANIES ADOPTED INVESTMENT & EXPANSION AND NEW PRODUCT DEVELOPMENT AS KEY GROWTH STRATEGIES 232
10.3 MARKET EVALUATION MATRIX 233
TABLE 209 MARKET EVALUATION MATRIX 234
10.4 REVENUE ANALYSIS 234
TABLE 210 REVENUE OF KEY COMPANIES IN LAST THREE YEARS 234
10.5 RANKING ANALYSIS OF KEY MARKET PLAYERS, 2021 235
FIGURE 33 RANKING OF TOP 5 PLAYERS IN PHARMACEUTICAL PACKAGING MARKET, 2021 235
10.5.1 BERRY GLOBAL INC. 235
10.5.2 AMCOR PLC 235
10.5.3 APTARGROUP, INC. 235
10.5.4 GERRESHEIMER AG 236
10.5.5 SCHOTT AG 236
10.6 MARKET SHARE ANALYSIS 236
FIGURE 34 PHARMACEUTICAL PACKAGING MARKET SHARE, BY COMPANY (2021) 236
TABLE 211 PHARMACEUTICAL PACKAGING MARKET: DEGREE OF COMPETITION 237
10.7 COMPANY EVALUATION MATRIX (TIER 1) 237
10.7.1 STARS 237
10.7.2 PERVASIVE PLAYERS 237
10.7.3 EMERGING LEADERS 237
10.7.4 PARTICIPANTS 237
FIGURE 35 PHARMACEUTICAL PACKAGING MARKET: COMPANY EVALUATION MATRIX FOR TIER 1 COMPANIES, 2021 238
10.8 STRENGTH OF PRODUCT PORTFOLIO 239
10.9 BUSINESS STRATEGY EXCELLENCE 239
10.10 COMPANY EVALUATION MATRIX (START-UPS AND SMES) 240
10.10.1 PROGRESSIVE COMPANIES 240
10.10.2 RESPONSIVE COMPANIES 240
10.10.3 STARTING BLOCKS 240
10.10.4 DYNAMIC COMPANIES 240
FIGURE 36 PHARMACEUTICAL PACKAGING MARKET: COMPANY EVALUATION MATRIX FOR START-UPS AND SMES, 2021 241
10.11 STRENGTH OF PRODUCT PORTFOLIO (START-UPS AND SMES) 242
10.12 BUSINESS STRATEGY EXCELLENCE (START-UPS AND SMES) 243
10.13 COMPETITIVE BENCHMARKING 243
TABLE 212 PHARMACEUTICAL PACKAGING MARKET: DETAILED LIST OF COMPANIES 243
10.13.1 COMPANY DRUG DELIVERY MODE FOOTPRINT 245
TABLE 213 OVERALL DRUG DELIVERY MODE FOOTPRINT 245
10.13.2 COMPANY TYPE FOOTPRINT 246
TABLE 214 OVERALL TYPE FOOTPRINT 246
10.13.3 COMPANY REGION FOOTPRINT 248
TABLE 215 OVERALL REGION FOOTPRINT 248
10.13.4 COMPANY FOOTPRINT 249
TABLE 216 OVERALL COMPANY FOOTPRINT 249
10.14 COMPETITIVE SITUATION AND TRENDS 250
10.14.1 PRODUCT LAUNCHES 250
TABLE 217 PHARMACEUTICAL PACKAGING: PRODUCT LAUNCHES, 2018–NOVEMBER 2022 250
10.14.2 DEALS 254
TABLE 218 PHARMACEUTICAL PACKAGING: DEALS, 2018–NOVEMBER 2022 254
10.14.3 OTHERS 256
TABLE 219 PHARMACEUTICAL PACKAGING MARKET: OTHERS, 2018–NOVEMBER 2022 256
11 COMPANY PROFILES 262
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1 BERRY GLOBAL INC. 262
TABLE 220 BERRY GLOBAL: COMPANY OVERVIEW 262
FIGURE 37 BERRY GLOBAL: COMPANY SNAPSHOT 263
TABLE 221 BERRY GLOBAL: PRODUCTS OFFERED 263
TABLE 222 BERRY GLOBAL: PRODUCT LAUNCHES 264
TABLE 223 BERRY GLOBAL: DEALS 264
TABLE 224 BERRY GLOBAL: OTHER DEVELOPMENTS 265
11.2 GERRESHEIMER AG 266
TABLE 225 GERRESHEIMER AG: COMPANY OVERVIEW 266
FIGURE 38 GERRESHEIMER AG: COMPANY SNAPSHOT 267
TABLE 226 GERRESHEIMER AG: PRODUCTS OFFERED 268
TABLE 227 GERRESHEIMER AG: PRODUCT LAUNCHES 269
TABLE 228 GERRESHEIMER AG: OTHER DEVELOPMENTS 270
11.3 AMCOR PLC 272
TABLE 229 AMCOR PLC: COMPANY OVERVIEW 272
FIGURE 39 AMCOR: COMPANY SNAPSHOT 273
TABLE 230 AMCOR: PRODUCTS OFFERED 273
TABLE 231 AMCOR: PRODUCT LAUNCHES 275
TABLE 232 AMCOR: DEALS 275
TABLE 233 AMCOR: OTHER DEVELOPMENTS 276
 
11.4 SCHOTT AG 277
TABLE 234 SCHOTT AG: COMPANY OVERVIEW 277
FIGURE 40 SCHOTT AG: COMPANY SNAPSHOT 278
TABLE 235 SCHOTT AG: PRODUCTS OFFERED 278
TABLE 236 SCHOTT AG: PRODUCT LAUNCHES 279
TABLE 237 SCHOTT AG: DEALS 279
TABLE 238 SCHOTT AG: OTHER DEVELOPMENTS 280
11.5 APTARGROUP, INC. 282
TABLE 239 APTARGROUP, INC.: COMPANY OVERVIEW 282
FIGURE 41 APTARGROUP: COMPANY SNAPSHOT 283
TABLE 240 APTARGROUP: PRODUCTS OFFERED 283
TABLE 241 APTARGROUP: PRODUCT LAUNCHES 284
TABLE 242 APTARGROUP: DEALS 285
TABLE 243 APTARGROUP: OTHER DEVELOPMENTS 285
11.6 BECTON, DICKINSON AND COMPANY 287
TABLE 244 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 287
FIGURE 42 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT 287
TABLE 245 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED 288
TABLE 246 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES 288
TABLE 247 BECTON, DICKINSON AND COMPANY: DEALS 289
TABLE 248 BECTON, DICKINSON AND COMPANY: OTHER DEVELOPMENTS 289
11.7 WESTROCK COMPANY 290
TABLE 249 WESTROCK COMPANY: COMPANY OVERVIEW 290
FIGURE 43 WESTROCK COMPANY: COMPANY SNAPSHOT 291
TABLE 250 WESTROCK COMPANY: PRODUCTS OFFERED 291
TABLE 251 WESTROCK COMPANY: OTHER DEVELOPMENTS 292
11.8 NIPRO CORPORATION 293
TABLE 252 NIPRO CORPORATION: COMPANY OVERVIEW 293
FIGURE 44 NIPRO CORPORATION: COMPANY SNAPSHOT 293
TABLE 253 NIPRO CORPORATION: PRODUCTS OFFERED 294
TABLE 254 NIPRO CORPORATION: DEALS 294
11.9 CATALENT, INC. 295
TABLE 255 CATALENT, INC.: COMPANY OVERVIEW 295
FIGURE 45 CATALENT: COMPANY SNAPSHOT 295
TABLE 256 CATALENT: PRODUCTS OFFERED 296
TABLE 257 CATALENT: DEALS 296
TABLE 258 CATALENT: OTHER DEVELOPMENTS 297
11.10 SEALED AIR 298
TABLE 259 SEALED AIR: COMPANY OVERVIEW 298
FIGURE 46 SEALED AIR: COMPANY SNAPSHOT 298
TABLE 260 SEALED AIR: PRODUCTS OFFERED 299
TABLE 261 SEALED AIR: PRODUCT LAUNCHES 299
TABLE 262 SEALED AIR: DEALS 300
11.11 WEST PHARMACEUTICAL SERVICES, INC. 301
TABLE 263 WEST PHARMACEUTICAL SERVICES: COMPANY OVERVIEW 301
FIGURE 47 WEST PHARMACEUTICAL SERVICES: COMPANY SNAPSHOT 301
TABLE 264 WEST PHARMACEUTICAL SERVICES: PRODUCTS OFFERED 302
TABLE 265 WEST PHARMACEUTICAL SERVICES: PRODUCT LAUNCHES 302
TABLE 266 WEST PHARMACEUTICAL SERVICES: OTHER DEVELOPMENTS 303
11.12 OTHERS 304
11.12.1 ALPLA WERKE ALWIN LEHNER GMBH & CO KG 304
TABLE 267 ALPLA WERKE ALWIN LEHNER GMBH & CO KG: COMPANY OVERVIEW 304
11.12.2 ARDAGH GROUP S.A. 305
TABLE 268 ARDAGH GROUP S.A.: COMPANY OVERVIEW 305
11.12.3 CCL INDUSTRIES INC. 306
TABLE 269 CCL INDUSTRIES INC.: COMPANY OVERVIEW 306
11.12.4 FRANK NOE EGYPT LTD. 307
TABLE 270 FRANK NOE EGYPT LTD.: COMPANY OVERVIEW 307
11.12.5 GAPLAST GMBH 308
TABLE 271 GAPLAST GMBH: COMPANY OVERVIEW 308
11.12.6 LONZA GROUP LTD. 309
TABLE 272 LONZA GROUP LTD.: COMPANY OVERVIEW 309
11.12.7 MONDI GROUP 310
TABLE 273 MONDI GROUP: COMPANY OVERVIEW 310
11.12.8 NOLATO AB 311
TABLE 274 NOLATO AB: COMPANY OVERVIEW 311
11.12.9 ORIGIN PHARMA PACKAGING 312
TABLE 275 ORIGIN PHARMA PACKAGING: COMPANY OVERVIEW 312
11.12.10 COMAR 313
TABLE 276 COMAR: COMPANY OVERVIEW 313
11.12.11 BILCARE LIMITED 314
TABLE 277 BILCARE LIMITED: COMPANY OVERVIEW 314
11.12.12 SGD PHARMA 315
TABLE 278 SGD PHARMA: COMPANY OVERVIEW 315
11.12.13 SILGAN HOLDINGS INC. 316
TABLE 279 SILGAN HOLDINGS INC.: COMPANY OVERVIEW 316
11.12.14 VETTER PHARMA INTERNATIONAL GMBH 317
TABLE 280 VETTER PHARMA INTERNATIONAL GMBH: COMPANY OVERVIEW 317
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
 
12 APPENDIX 318
12.1 DISCUSSION GUIDE 318
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 322
12.3 CUSTOMIZATION OPTIONS 324
12.4 RELATED REPORTS 324
12.5 AUTHOR DETAILS 325

★調査レポート[世界の医薬品包装市場（～2027年）：原材料別（プラスチック、紙＆板紙、ガラス、金属）、種類別（プラスチックボトル、ブリスター、キャップ＆クローサー、ラベル＆付属品、プレフィルドシリンジ）、薬物送達別、地域別] (コード：CH3482-23)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の医薬品包装市場（～2027年）：原材料別（プラスチック、紙＆板紙、ガラス、金属）、種類別（プラスチックボトル、ブリスター、キャップ＆クローサー、ラベル＆付属品、プレフィルドシリンジ）、薬物送達別、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の医薬品包装市場（～2028年）：原材料別（プラスチック、紙・板紙、ガラス、金属）、種類別（プラスチックボトル、ブリスター、キャップ・クロージャー、ラベル・付属品、プレフィルドシリンジ）、ドラッグデリバリー別、地域別
  • 世界の小児用安全包装市場（～2030年）：製品別（ブリスター＆クラムシェル、ジョイントコンテナーチューブ、バッグ＆パウチ、容器、キャップ＆クロージャー）、素材別（ガラス、金属、紙＆板紙、プラスチック）、包装タイプ別、エンドユーザー別、地域別
  • 世界の治験用包装市場（～2030年）：製品種類別（シリンジ、バイアル＆アンプル、ボトル、バッグ＆パウチ、ブリスター、チューブ、小袋、キット＆パック、その他）、治験種類別（治療・予防、診断、その他）、素材別（プラスチック、ガラス、金属、紙、段ボール、その他）、エンドユーザー別、地域別
  • 世界の非経口用製剤包装市場（～2030年）：製品種類別（バイアル、プレフィルドシリンジ、カートリッジ、バッグ、その他）、素材種類別（ガラス、プラスチック、その他）、包装種類別、地域別
  • 世界の持続可能な医薬品包装市場（～2027）：原材料別（プラスチック、紙＆板紙、ガラス、金属）、製品種類別、プロセス別（リサイクル、再利用、生分解）、包装種類別（一次包装）、地域別
  • 世界のスキンケア用包装市場（～2027）：材料別（金属、ガラス、紙、ポリマー、プラスチック、その他）、容器種類別（瓶、チューブ、サシェ、スポイト、キャップ、クロージャー、その他）

    • ◆H&Iグローバルリサーチのお客様（例）◆